Structure–Activity Relationship and Molecular Docking of Quinazolinones Inhibiting Expression of COX-2, IL-1β, iNOS, and TNF-α through NF-κB Pathways
- 15 August 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 14 (9) , 1167-1173
Abstract
The quinazolinone scaffold is found in natural products and biologically active compounds, including inflammatory inhibitors. Major proteins or enzymes involved in the inflammation process are regulated by the amount of gene expression. Quinazolinone derivatives were investigated and developed against the inflammatory genes cyclooxygenase-2 (COX-2), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and inducible nitric oxide synthase (iNOS) in the lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage cell line. The mRNA expressions were measured using a real-time quantitative polymerase chain reaction (RT-qPCR). Quinazolinone compounds at 62.5 μM demonstrated anti-COX-2 and anti-IL-1β mRNA expressions down to 0.50% and 3.10% gene expression, respectively, via inhibition of nuclear factor κB (NF-κB). Molecular docking was performed to explain the interaction between the binding site and the developed compounds as well as the structure-activity relationship of the quinazolinone moiety.Keywords
Funding Information
- Chiang Mai University
- Naresuan University (R2564C011, R2565E025, R2566B001, R2566C053)
This publication has 17 references indexed in Scilit:
- Synthesis and Biological Evaluation of Novel Bouchardatine Derivatives as Potential Adipogenesis/Lipogenesis Inhibitors for Antiobesity TreatmentJournal of Medicinal Chemistry, 2015
- Metal-free one-pot synthesis of 1,3-diazaheterocyclic compounds via I2-mediated oxidative C–N bond formationRSC Advances, 2015
- Synthesis, Characterization, and Anti-Inflammatory Activity of Newer Quinazolinone AnalogsJournal of Pharmaceutics, 2013
- Molecular docking and synthesis of novel quinazoline analogues as inhibitors of transcription factors NF-κB activation and their anti-cancer activitiesBioorganic & Medicinal Chemistry, 2013
- New quinazolinone–pyrimidine hybrids: Synthesis, anti-inflammatory, and ulcerogenicity studiesEuropean Journal of Medicinal Chemistry, 2012
- Synthesis, characterization, and evaluation of some novel 4(3H)-quinazolinone derivatives as anti-inflammatory and analgesic agentsMedicinal Chemistry Research, 2012
- Antimalarial Activities and Therapeutic Properties of Febrifugine AnalogsAntimicrobial Agents and Chemotherapy, 2005
- The discovery and development of antiinflammatory drugsArthritis & Rheumatism, 2004
- Discovery of quinazolines as a novel structural class of potent inhibitors of NF-κB activationBioorganic & Medicinal Chemistry, 2003
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory DiseasesNew England Journal of Medicine, 1997